CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Background-Free Analysis Of Mouse TILs

  Syngeneic mouse tumor models are crucial for immunotherapy research, but variability in TILs and nonspecific binding complicate analysis. Discover how blocking reagents help but make the process more labor-intensive.

• How To Facilitate Good Clinical Data Review In Your Clinical Trial

  Learn how to create a system based on connectivity and automation, aggregated and usable data, flexible analysis, and methods of collaborative data review by centralizing analysis and communications.

• Mobilizing Compliance: USP 797 And 800 Pharmacy Trailer Fleet For VA Hospitals

  VA hospitals across the US are undergoing renovations to bring their facilities into compliance. The challenge was to design and manufacture a fleet of self-sufficient mobile compounding pharmacies.

• Immune Checkpoint Inhibitors Global Clinical Trials Landscape (2023)

  Dive into the forefront of immune checkpoint inhibitors clinical trials with an exploration of the latest trends and key findings.

• Optimizing Performance For De-Risked Lentiviral Vector Production

  Discover a de-risked, reproducible, and scalable platform for efficient GMP manufacturing of lentiviral vectors that maximizes titers and enriches recovery through upstream and downstream optimization.

• A Complete Macrophage Suppression Assay Workflow

  Analyze an experiment conducted to validate a macrophage suppression assay workflow and demonstrate a consistent in vitro macrophage suppression assay used in the validation process.

• High-Throughput Released N-Glycan Identification

  Learn about an all-inclusive sample preparation and high-throughput glycan analysis workflow with a customizable molecule-specific glycan library.

• Rapid And Robust Preclinical And Clinical Development Of CAR T-Cell Therapies

  Streamline CAR T-cell therapy development with integrated support for asset identification, IND submission, early-phase studies, and advanced real-time tracking solutions.

• Pioneering Gene Therapy In Rare Diseases

  Overcoming barriers to gene therapy development requires continued innovation in manufacturing processes, harmonized regulatory approaches, and outcome-based pricing models.

• Explore A High-Performing Basal Medium And Feed Pairing

  A customer sought to replace a chemically defined CHO medium with a more efficient medium and feed pairing strategy in bioreactors.